Hitting All the Marks
Building an at-home test is a bioengineering challenge

Hitting All the Marks

Since the pandemic, consumers want convenient, affordable and accurate at-home tests. And since these tests are effective in slowing the spread of disease, the Biden Administration has recently restarted offering at-home tests. But developing these tests and getting them into consumers’ hands is not easy.

Creating an inexpensive, at-home molecular test is a challenging bioengineering problem. The test has to hit three critical marks: accuracy, affordability and accessibility. If an accurate test has a $150 price tag or can only be conducted by trained professionals, that’s not going to work.

To get there, Sherlock Biosciences is mixing and matching three sophisticated technologies: our worldwide exclusive use of CRISPR in diagnostics, our proprietary synthetic biology and our artificial intelligence. These approaches are maturing now and are helping us hit all three marks. People will be able to go to their local pharmacy, or order online, pay out of pocket and have complete confidence in their results.

Because these technologies and decentralizing diagnostics are so new, there are questions about the regulatory landscape. Fortunately, COVID opened the door to how agencies are now thinking about at-home diagnostics. Consumers have proven their ability to assess diagnostic results and seek out additional care.

Our first tests will be in the sexual wellness arena for diseases like chlamydia and gonorrhea. The FDA has approved OTC tests for pregnancy, respiratory diseases and HIV, helping to clear a path forward.

#AI, #crispr, #syntheticbiology #athomestdtest #STItesting #athometesting #stdtesting #pcrtesting #diagnostictesting #bioengineering

Larry Costello

Worldwide Device and Diagnostics thermoplastics Development at SMC Ltd

1 年

Let SMC LTD medical help , nearby with thermoplastics based solutions , with repeatable performance and innovation , signed off with ISO 13485 med device validation. We are eager to assist your cutting edge platform! Let’s go Sherlock Bio!

要查看或添加评论,请登录

Bryan Dechairo的更多文章

  • If We Build It…

    If We Build It…

    Many people struggle with getting tested at the doctor or in a lab setting. Unfortunately, people don't always feel…

    3 条评论
  • Selling Diagnostics Directly to Consumers

    Selling Diagnostics Directly to Consumers

    The pandemic changed how consumers think about accessing testing. After experiencing Covid tests, consumers want direct…

    4 条评论
  • The Fruits of Disruption

    The Fruits of Disruption

    The ability to access diagnostic answers at home is an enormous departure from the existing testing workflow. Right…

  • Accelerating our path to commercialization

    Accelerating our path to commercialization

    When I joined Sherlock a year and a half ago, I knew I'd be part of a team that would disrupt diagnostics and make a…

    12 条评论

社区洞察

其他会员也浏览了